
Epigral Ltd Technical Momentum Shifts Amid Bearish Sentiment
2026-09-16 08:09:29Epigral Ltd, a small-cap player in the Specialty Chemicals sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more pronounced bearish trend. Recent technical indicators, including MACD, RSI, moving averages, and Bollinger Bands, signal increasing downside pressure, reflecting the stock’s underperformance relative to benchmarks such as the Sensex.
Read full news article
Epigral Ltd is Rated Sell by MarketsMOJO
2026-09-10 10:10:26Epigral Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 26 December 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 10 September 2026, providing investors with an up-to-date view of the company’s performance and outlook.
Read full news article
Epigral Ltd Valuation Shifts Signal Renewed Price Attractiveness Amid Specialty Chemicals Sector
2026-09-10 08:01:18Epigral Ltd, a small-cap player in the Specialty Chemicals sector, has seen a notable shift in its valuation parameters, moving from a fair to an attractive rating. Despite recent headwinds reflected in its share price decline, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now present a compelling case for investors seeking value within a challenging market environment.
Read full news article
Epigral Ltd is Rated Sell by MarketsMOJO
2026-08-30 10:10:14Epigral Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 26 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 30 August 2026, providing investors with an up-to-date view of the company’s performance and outlook.
Read full news article
Epigral Ltd Valuation Shifts: From Attractive to Fair Amid Specialty Chemicals Sector Dynamics
2026-08-25 08:02:05Epigral Ltd, a small-cap player in the specialty chemicals sector, has witnessed a notable shift in its valuation parameters, moving from an attractive to a fair valuation grade. This change reflects evolving market perceptions amid a backdrop of mixed financial metrics and sector-wide valuation disparities. Investors are now reassessing the company’s price attractiveness relative to its historical averages and peer group, prompting a deeper analysis of its price-to-earnings (P/E) and price-to-book value (P/BV) ratios alongside operational returns and market performance.
Read full news article
Epigral Ltd Shows Mixed Technical Signals Amid Mild Recovery
2026-08-21 08:04:15Epigral Ltd, a specialty chemicals small-cap, has exhibited a notable shift in its technical momentum, moving from a bearish stance to a mildly bearish trend. Despite a recent day gain of 3.88%, the stock’s technical indicators present a complex picture, with some signals suggesting cautious optimism while others maintain a bearish outlook. This article analyses the latest technical parameters, including MACD, RSI, moving averages, and other momentum indicators, to provide a comprehensive view of Epigral’s current market positioning.
Read full news article
Epigral Ltd is Rated Sell
2026-08-19 10:10:58Epigral Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 26 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 August 2026, providing investors with an up-to-date view of the company’s performance and outlook.
Read full news article
Epigral Ltd Technical Momentum Shifts Amid Bearish Sentiment
2026-08-19 08:05:12Epigral Ltd, a specialty chemicals small-cap, has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend despite some mildly bullish weekly signals. The stock’s recent price action and technical parameters suggest caution for investors as the company navigates a challenging market environment.
Read full news article
Epigral Ltd Technical Momentum Shifts Amid Mixed Market Signals
2026-08-18 08:07:35Epigral Ltd, a small-cap player in the Specialty Chemicals sector, has exhibited a nuanced shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook. Despite a modest day change of 0.22% to close at ₹1,100.80, the stock’s technical indicators reveal a complex interplay of bullish and bearish signals, reflecting cautious investor sentiment amid broader market volatility.
Read full news articleAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
31-Aug-2026 | Source : BSEEpigral Limited has informed the Exchange about Investor / Analyst Plant Visit on Thursday 03.09.2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
18-Aug-2026 | Source : BSEEpigral Limited has informed the Exchange about One-on-One Meeting with Investor / Analyst on thursday 20.08.2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
07-Aug-2026 | Source : BSEEpigral Limited hereby informs that the officials of the Company are participating in EMKAY Confluence 2026 on 12th August 2026
Corporate Actions
No Upcoming Board Meetings
Epigral Ltd has declared 50% dividend, ex-date: 01 Jun 26
No Splits history available
No Bonus history available
No Rights history available






